Author: Liu, Weiwei; Ding, Chan
Title: Roles of LncRNAs in Viral Infections Document date: 2017_5_26
ID: 02zv1gsq_29
Snippet: Two nuclear, highly structured and abundant viral transcripts EBER1 (167 nt) and EBER2 (172 nt) in latently EBV-infected cells are produced by EBV (Iwakiri, 2016) . EBER are polyadenylated, ncRNAs that are transcribed by RNA polymerase III (pol III) (Iwakiri, 2016) . EBERs play key roles in antiviral innate immunity via interaction with cellular proteins (Iwakiri and Takada, 2010) . EBERs are recognized by RIG-I and activate its downstream signal.....
Document: Two nuclear, highly structured and abundant viral transcripts EBER1 (167 nt) and EBER2 (172 nt) in latently EBV-infected cells are produced by EBV (Iwakiri, 2016) . EBER are polyadenylated, ncRNAs that are transcribed by RNA polymerase III (pol III) (Iwakiri, 2016) . EBERs play key roles in antiviral innate immunity via interaction with cellular proteins (Iwakiri and Takada, 2010) . EBERs are recognized by RIG-I and activate its downstream signaling to induce expression of type-I IFNs in EBV-infected cells (Samanta et al., 2006) . Furthermore, EBERs induce IL-10 expression through IRF3, but not NF-κB activation, in BL (Burkitt's lymphoma) cells, suggesting that EBER acts as an autocrine growth factor in BL cells (Kitagawa et al., 2000; Samanta et al., 2008) . In addition, EBER also contributes to oncogenesis . For example, in BL, EBERs counteract IFN-α-induced apoptosis via binding to PKR and inhibition of its phosphorylation .
Search related documents:
Co phrase search for related documents- innate immunity and key role: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54
- innate immunity and key role play: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- innate immunity and NF κB activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- innate immunity and RIG recognize: 1, 2
- innate immunity and RNA polymerase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- innate immunity and type expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41
- innate immunity and type expression induce: 1, 2, 3
- key role and NF κB activation: 1, 2, 3, 4, 5, 6
- key role and RNA polymerase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- key role and type expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- key role play and RNA polymerase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- key role play and type expression: 1, 2, 3, 4
- NF κB activation and RIG recognize: 1
- NF κB activation and RNA polymerase: 1, 2
- NF κB activation and type expression: 1, 2, 3, 4, 5, 6, 7, 8
- phosphorylation inhibition pkr and RNA polymerase: 1
- RIG recognize and type expression: 1, 2, 3
- RNA polymerase and type expression: 1, 2, 3, 4, 5, 6
- RNA polymerase and viral transcript: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date